Aberdeen Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Aberdeen Wealth Management's NVS Position: Q3 2026 in Review
Aberdeen Wealth Management increased its Novartis (NVS) stake by 92% in Q3 2026, buying an estimated $840K and bringing the position to 11,580 shares worth $1.65M. The position accounts for 0.65% of the portfolio, ranked #29.
Aberdeen Wealth Management first reported a position in NVS in Q4 2019 and has held it in 24 quarters since. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Aberdeen Wealth Management held 11,580 shares of Novartis worth $1.65M as of Q3 2026.
- Aberdeen Wealth Management bought 5,535 Novartis shares in Q3 2026, an estimated $840K.
- Novartis made up 0.65% of Aberdeen Wealth Management's portfolio in Q3 2026, its #29 holding.
- Aberdeen Wealth Management first reported a position in Novartis in Q4 2019 and has held it in 24 quarters since.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Aberdeen Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.